HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Cartalax |
|---|---|
| Class | Longevity, cognitive & bioregulators |
| Molecular formula | C12H19N3O8 |
| Molecular weight | 333.29 g/mol |
| Sequence | Ala-Glu-Asp |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 20mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture; short-term room-temperature transit is tolerated. After reconstitution, keep refrigerated at 2–8°C and use within the validated stability window. For laboratory research use only. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Cartalax is a synthetic Ala-Glu-Asp (AED) tripeptide bioregulator of the Khavinson short-peptide class, studied in preclinical cartilage and connective-tissue models and supplied by Pepti as a research-use, private-label OEM product.
Documentation
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Cartalax reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Cartalax is a synthetic Ala-Glu-Asp (AED) tripeptide bioregulator of the Khavinson short-peptide class. Pepti supplies it as a lyophilized white powder in sealed vials for laboratory research use, in a 20 mg vial format with a 50-vial minimum order, and offers private-label / OEM options.
Each batch is accompanied by a Certificate of Analysis (COA) reporting HPLC purity and mass-spectrometry (MS) identity confirmation. Additional documentation such as TDS and safety data can be provided to qualified B2B accounts on request.
Cartalax is manufactured to a typical purity of ≥98% by HPLC. The exact figure for each lot is stated on the batch-specific COA, and tighter specifications can be quoted on RFQ.
Yes. Pepti is a China-based OEM and private-label manufacturer. Custom fill weights, vial labeling, kitting, and bulk volumes beyond the catalog 20 mg / 50-vial MOQ are available under RFQ.
The exact all-L Ala-Glu-Asp tripeptide is catalogued in PubChem (CID 87815447) but has no assigned CAS registry number, and some CAS values circulating online actually map to unrelated compounds. Batch identity is confirmed by mass spec, and any regulatory identifiers are confirmed on RFQ.
Related compounds